1
ALL1
Alchem International Private LtdYear
1
ALL1
2021DEALS // DEV.
1
ALL1
DevelopmentsCountry
1
ALL1
INDIA1
ALL1
AIIMSTherapeutic Area
1
ALL1
Infections and Infectious DiseasesStudy Phase
1
ALL1
UndisclosedDeal Type
1
ALL1
InapplicableProduct Type
1
ALL1
Other Small MoleculeDosage Form
1
ALL1
Oral Troche/LozengeLead Product
1
ALL1
CurcuminoidTarget
1
ALL1
UndisclosedLead Product(s) : Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : AIIMS
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.
Product Name : Phytorelief-CC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 06, 2021
Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : AIIMS
Deal Size : Inapplicable
Deal Type : Inapplicable